{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:58Z","timestamp":1787169598481,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>It has been demonstrated that toll-like receptors (TLR2), TLR4, and TLR9 which were initially known for recognizing bacterial products are involved in the detection of viral components. It was planned to undertake a prospective longitudinal study among ethnically homogeneous antiretroviral treatment and antitubercular treatment na\u00efve human immunodeficiency virus (HIV)-positive patients representing the north Indian population. The aim of the study was to investigate the influence of TLR2, TLR4, and TLR9 polymorphism in HIV disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The present study was designed to investigate genetic polymorphism in TLRs (TLR2, TLR4, and TLR9) among HIV-infected patients with and without TB coinfection. The study population consisted of two groups: (i) HIV-positive patients without TB infection and disease (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 223, HIV-positive patients); (ii) HIV-positive patients with latent tuberculosis infection (LTBI) (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 150, HIV-positive LTBI patients). These participants were of either gender between 18 and 60 years of age and treatment na\u00efve for both TB and HIV. HIV-positive and HIV-positive LTBI patients were longitudinally followed up for t2 years to study HIV disease progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      On comparing TLR2 and TLR4 allelic and genotypic frequencies between 306 HIV-positive patients (no TB\/AIDS) and 47 HIV-positive patients progressed to active TB\/AIDS, no significant difference was observed between the two groups. The frequency of \u201cA\u201d allele in TLR9 was found to be significantly increased in 47 HIV-positive patients who progressed to active TB\/AIDS (61.7%) as compared to 42.16% in 306 HIV-positive patients (no TB\/AIDS), (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Furthermore, a significantly increased frequency of \u201cAA\u201d genotype in TLR9 was observed in 47 HIV-positive patients progressed to active TB\/AIDS (55.32%) as compared to 20.26% in HIV-positive patients (no TB\/AIDS).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Findings of the present study revealed that genetic variability in TLR9 may influence HIV disease progression. The AA genotype in TLR9 may be associated with progression to TB\/AIDS for 2 years in HIV-positive patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_190_22","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T02:03:48Z","timestamp":1678759428000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Influence of Genetic Variability in Toll-like Receptors (TLR 2, TLR 4, and TLR 9) on Human Immunodeficiency Virus-1 Disease Progression"],"prefix":"10.4103","volume":"12","author":[{"given":"Gaurav","family":"Kaushik","sequence":"first","affiliation":[{"name":"School of Allied Health Sciences, Sharda University, Greater Noida, Uttar Pradesh, India"},{"name":"Department of Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Vashishtha","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"R1-20240902","year":"2020","journal-title":"Global Report:UNAIDS Report on the Global AIDS Epidemic"},{"key":"R2-20240902","year":"2019","journal-title":"HIV Facts &Figures. NACO Report"},{"key":"R3-20240902","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/ijmy.ijmy_108_22","article-title":"Messenger RNA expression of toll-like receptors (TLR2, TLR4, and TLR9) in HIV-1 infected patients with and without tuberculosis co-infection","volume":"11","author":"Kaushik","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R4-20240902","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.3390\/ijms21176148","article-title":"A role of intracellular toll-like receptors (3, 7, and 9) in response to Mycobacterium tuberculosis and Co-Infection with HIV","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R5-20240902","year":"2019","journal-title":"Global Tuberculosis Report"},{"key":"R6-20240902","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/ijmy.ijmy_4_22","article-title":"Genetic polymorphism of toll-like receptors in HIV-I infected patients with and without tuberculosis co-infection","volume":"11","author":"Kaushik","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R7-20240902","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","article-title":"Diagnosis for latent tuberculosis infection:New alternatives","volume":"11","author":"Carranza","year":"2020","journal-title":"Front Immunol"},{"key":"R8-20240902","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/EDE.0000000000001271","article-title":"Time since infection and risks of future disease for individuals with Mycobacterium tuberculosis infection in the United States","volume":"32","author":"Menzies","year":"2021","journal-title":"Epidemiology"},{"key":"R9-20240902","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fped.2019.00350","article-title":"Immune response to Mycobacterium tuberculosis:A narrative review","volume":"7","author":"de","year":"2019","journal-title":"Front Pediatr"},{"key":"R10-20240902","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"R11-20240902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12763","article-title":"Toll-like receptor signaling in primary immune deficiencies","volume":"1356","author":"Maglione","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"R12-20240902","doi-asserted-by":"crossref","first-page":"672346","DOI":"10.3389\/fimmu.2021.672346","article-title":"Toll-like receptors gene polymorphisms in autoimmune disease","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"R13-20240902","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1185449","article-title":"The population dynamics and control of tuberculosis","volume":"328","author":"Dye","year":"2010","journal-title":"Science"},{"key":"R14-20240902","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/QAD.0b013e3282f2dbe7","article-title":"Immune activation and AIDS pathogenesis","volume":"22","author":"Sodora","year":"2008","journal-title":"AIDS"},{"key":"R15-20240902","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41467-022-28130-0","article-title":"Low CCR5 expression protects HIV-specific CD4+T cells of elite controllers from viral entry","volume":"13","author":"Claireaux","year":"2022","journal-title":"Nat Commun"},{"key":"R16-20240902","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12981-019-0239-x","article-title":"HIV-2 as a model to identify a functional HIV cure","volume":"16","author":"Esbj\u00f6rnsson","year":"2019","journal-title":"AIDS Res Ther"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_190_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:09:36Z","timestamp":1787166576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_190_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_190_22","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-11-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}